When should you suspect if your patient is an Anabolic-Androgenic Steroid User? Evidence-Based literature review of usage patterns changes and clinical implications for medical practice (2005-2025)
DOI:
https://doi.org/10.12775/JEHS.2026.88.68269Keywords
AAS, adverse effects, clinical practiceAbstract
Background: Anabolic-androgenic steroid (AAS) use has evolved into a significant public health concern affecting diverse populations beyond elite athletics.
Objective: To examine evidence-based changes in AAS usage patterns including demographics, motivations, and health consequences from 2005-2025 using systematic reviews and peer-reviewed research.
Methods: Literature review of peer-reviewed studies and systematic reviews from PubMed and National Health Institute Library focusing on AAS epidemiology, demographic changes, and health consequences published between 2005-2025.
Results: Global lifetime prevalence of AAS use is estimated at 6-29%. Female participation is estimated to be constantly growing. Evidence indicates expansion beyond traditional athletic populations with significant cardiovascular, psychiatric, and reproductive health consequences.
Conclusions: AAS use represents a widespread public health concern requiring enhanced clinical awareness and evidence-based management approaches among medical practitioners.
References
AlShareef S, Gokarakonda SB, Marwaha R. Anabolic Steroid Use Disorder. StatPearls Publishing; 2025 Jan (Updated 2023 Jun 20). www.ncbi.nlm.nih.gov/books/NBK538174/
Mingxing L, Yanfei Y. Adverse Effects of Anabolic Androgenic Steroid Abuse in Athletes and Physically Active Individuals: A Systematic Review and Meta-Analysis. Substance Use & Misuse. 2025;60(6). PMID: 39945139.
DOI: 10.1080/10826084.2025.2460986
Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24(5):383-98. PMID: 24582699.
DOI: 10.1016/j.annepidem.2014.01.009
Piatkowski T, et al. What is the prevalence of anabolic-androgenic steroid use among women? A systematic review. Addiction. 2024. PMID: 39134450.
DOI: 10.1111/add.16643
Hoseini R, Hoseini Z. Exploring the prevalence of anabolic steroid use among men and women resistance training practitioners after the COVID-19 pandemic. BMC Public Health. 2024;24(1):798. DOI: 10.1186/s12889-024-18292-5
Cohen J et al. A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr 2007 Oct 11:4:12. DOI: doi.org/10.1186/1550-2783-4-12
Albaker W, Alkhars A, Elamin Y, Jatoi N, Boumarah D, Al-Hariri M. Anabolic–Androgenic Steroid Abuse among Gym Users, Eastern Province, Saudi Arabia. Medicina. 2021; 57(7):703.
DOI: doi.org/10.3390/medicina57070703
Al Hamid A et. al. Steroid and illicit drug abuse in the health and fitness community: A systematic review of evidence. Emerging Trends in Drugs, Addictions, and Health, Volume 5, 2025.
DOI: doi.org/10.1016/j.etdah.2025.100172
McCreary DR, Hildebrandt TB, Heinberg LJ, Boroughs M, Thompson JK. A review of body image influences on men's fitness goals and supplement use. Am J Mens Health. 2007 Dec;1(4):307-16. PMID: 19482812
DOI: doi.org/10.1177/1557988306309408
Vasiliu O. At the Crossroads between Eating Disorders and Body Dysmorphic Disorders - The Case of Bigorexia Nervosa. Brain Sciences. 2023; 13(9):1234.
DOI: doi.org/10.3390/brainsci13091234
Baggish AL, et al. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. 2017;135(21):1991-2002. PMC: PMC5614517.
Hassan N, Salem M, Sayed M. Doping and effects of anabolic androgenic steroids on the heart: histological, ultrastructural, and echocardiographic assessment in strength athletes. Human & Experimental Toxicology. 2009;28(5):273-283.
DOI: 10.1177/0960327109104821
Torrisi M, Pennisi G, Russo I, Amico F, Esposito M, Liberto A, Cocimano G, Salerno M, Li Rosi G, Di Nunno N, et al. Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review. Medicina. 2020; 56(11):587.
DOI: https://doi.org/10.3390/medicina56110587
Windfeld-Mathiasen J, Heerfordt IM, Dalhoff KP, Andersen JT, Andersen MA, Johansson KS, Biering-Sørensen T, Olsen FJ, Horwitz H. Cardiovascular Disease in Anabolic Androgenic Steroid Users. Circulation. 2025 Mar 25;151(12):828-834.
DOI: https://doi.org/10.1161/CIRCULATIONAHA.124.071117
Vanberg P, Atar D. Androgenic anabolic steroid abuse and the cardiovascular system. Handb Exp Pharmacol. 2010;(195):411-57.
DOI: https://doi.org/10.1007/978-3-540-79088-4_18
Alhusban A, et al. Steroid‐Induced Cardiomyopathy: Insights From a Systematic Literature Review and a Case Report. Clinical Case Reports. 2025;13(2).
DOI: https://doi.org/10.1002/ccr3.70171
Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract. 2009 Jul;15(4):289-305.
DOI: https://doi.org/10.1097/01.pra.0000358315.88931.fc
Nackeeran S, et al. Anabolic-Androgenic Steroid Use is Associated with Major Depressive Disorder and Suicide Attempt: Analysis of a Multi-National Database. J Sex Med. 2022.
DOI: https://doi.org/10.1016/j.jsxm.2022.01.106
Gestsdottir S, et al. Prevalence, mental health and substance use of anabolic steroid users: a population-based study on young individuals. Scand J Public Health. 2021;49(3):303-312.
DOI: https://doi.org/10.1177/1403494820973096
Borjesson A, et al. Male Anabolic Androgenic Steroid Users with Personality Disorders Report More Aggressive Feelings, Suicidal Thoughts, and Criminality. Subst Use Misuse. 2020;55(11):1886-1895. PMC: PMC7353874.
DOI: https://doi.org/10.3390/medicina56060265
Ip EJ, Lu DH, Barnett MJ, Tenerowicz MJ, Vo JC, Perry PJ. Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy. 2012 Oct;32(10):910-9.
DOI: https://doi.org/10.1002/j.1875-9114.2012.01123
Sagoe D, McVeigh J, Bjørnebekk A, Essilfie MS, Andreassen CS, Pallesen S. Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Subst Abuse Treat Prev Policy. 2015 Mar 15;10:12.
DOI: https://doi.org/10.1186/s13011-015-0006-5
Grönbladh A, Nylander E, Hallberg M. The neurobiology and addiction potential of anabolic androgenic steroids and the effects of growth hormone. Brain Res Bull. 2016 Sep;126(Pt 1):127-137.
DOI: https://doi.org/10.1016/j.brainresbull.2016.05.003
Vauhkonen P, Oura P, Kriikku P, Mäyränpää MI, Lindroos K. Association of anabolic androgenic steroid use with perimortem polypharmacy, antemortem prescription drug use, and utilization of health care services - A Finnish triple register study of forensic autopsy cases. Forensic Sci Int. 2024 Mar;356:111947.
DOI: https://doi.org/10.1016/j.forsciint.2024.111947
Kanayama G, Hudson JI, Pope HG Jr. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008 Nov 1;98(1-2):1-12.
DOI: https://doi.org/10.1016/j.drugalcdep.2008.05.004
Mulawkar PM, Maheshwari PN, Gauhar V, Agrawal SG, Mohammed TO, Singh AG, Tak GR, Shah US, Shukla DP, Mamankar D. Use of Anabolic-Androgenic Steroids and Male Fertility: A Systematic Review and Meta-analysis. J Hum Reprod Sci. 2023 Oct-Dec;16(4):268-285.
DOI: https://doi.org/10.4103/jhrs.jhrs_90_23
Santos BM, de Souza JPA, Goulart LRP, Petrine JCP, Alves FHF, Del Bianco-Borges B. Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives. Saudi Pharm J. 2024 Dec;32(12):102205.
DOI: https://doi.org/10.1016/j.jsps.2024.102205
Nieschlag E, Vorona E. MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015 Aug;173(2):R47-58.
DOI: https://doi.org/10.1530/eje-15-0080
Bond P, Smit DL, de Ronde W. Anabolic-androgenic steroids: How do they work and what are the risks? Front Endocrinol (Lausanne). 2022 Dec 19;13:1059473.
DOI: https://doi.org/10.3389/fendo.2022.1059473
Al Hashimi M, Farahat Y, Kandil H, Al Khalidi I. Androgenic-anabolic steroid abuse trend and management: A prospective, cross-sectional, questionnaire-based survey. Health Sci Rep. 2023 Jan 9;6(1):e1032.
DOI: https://doi.org/10.1002/hsr2.1032
Heerfordt IM, Windfeld-Mathiasen J, Dalhoff KP, Trærup Andersen J, Horwitz H. Disability pension among androgenic-anabolic steroid users. Scand J Public Health. 2025 May 20:14034948251340489.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Adrianna Pielech, Patrycja Dadyńska, Marek Wilczyński, Paweł Kwiecień, Michał Kwiecień, Julianna Zielska

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 20
Number of citations: 0